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Advances in the treatment of myocardial infarction (MI) have improved survival after
ischemic cardiac injury. Post-infarct structural and functional remodeling results in elec-
trophysiologic substrates at risk for monomorphic ventricular tachycardia (MMVT). Char-
acterization of this substrate using a variety of clinical and investigative tools has
improved our understanding of MMVT circuits, and has accelerated the development of
device and catheter-based therapies aimed at identification and elimination of this
arrhythmia.
This review will discuss the central role of the ischemic heart disease substrate in the
development MMVT. Electrophysiologic characterization of the post-infarct myocardium
using bipolar electrogram amplitudes to delineate scar border zones will be reviewed.
Functional electrogram determinants of reentrant circuits such as isolated late potentials
will be discussed. Strategies for catheter ablation of reentrant ventricular tachycardia,
including structural and functional targets will also be examined, as will the role of the
epicardial mapping and ablation in the management of recurrent MMVT.
Copyright ª 2013, Cardiological Society of India. All rights reserved.1. Introduction
Significant improvements in the prevention, diagnosis, and
treatment of coronary artery disease have resulted in higher
rates of survival following acutemyocardial infarctions (MIs).1
As a result of rapid reperfusion, increased implementation of
hemodynamic support devices, and adherence to antiplatelet
and neurohormonal therapies, an increasing number of pa-
tients with healed myocardial infarcts require electrophysio-
logic management for the treatment and prevention of
ventricular arrhythmias.23; fax: þ1 310 794 6492.
(O.A. Ajijola).
2013, Cardiological SocieThis review will concentrate on the structural and func-
tional features of ischemic myocardial substrates in the gen-
esis of ventricular arrhythmias after healed MI. Polymorphic
ventricular tachycardia and ventricular fibrillation, which are
more prevalent in the acute to sub-acute ischemic period, will
not be discussed. Components of the ischemic car-
diomyopathic substrate, which facilitate the reentrant path-
ways characteristic of monomorphic ventricular tachycardia
(MMVT) will be discussed, along with implications for
catheter-basedmanagement of these arrhythmias. Automatic
ventricular tachycardia, which may appear monomorphic,
will not be discussed in this review.ty of India. All rights reserved.
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2.1. Structural remodeling
The healing phase of infarcted myocardium is characterized
by infiltration of the infarcted myocardial tissue by inflam-
matory cells. Necrotic myocytes are cleared by macrophages,
and replacement fibrous tissue, consisting of collagen, is
deposited by fibroblasts over the next days, weeks, and
months. The ischemic wavefront of necrosis proceeds from
the subendocardium to epicardium during myocardial
ischemia,3 and scar deposition parallels this sequence. Critical
elements arise during this process, which permit the reen-
trant circuits that characterize MMVT. The heterogeneous
process of myocyte resorption and collagen deposition results
in islands of surviving myocardial cells within healed infarct
scars as shown in Fig. 1.4 These preservedmyocardial bundles
exist as a “labyrinth” in three dimensions, involving the
endocardium, mid-myocardium, and epicardium. The func-
tional electrophysiologic characteristics of these channelswill
be discussed in detail later in this review.
Channels that facilitate or sustain MMVT, consist of an
entry site, a protected isthmus, and a breakthrough exit site
that activates the ventricles.5 Functional or fixed conduction
slowing and block in a channel can result in an excitable gap
for reentry. These localized regions of slow conduction within
scar exhibit “zig-zag” conduction during normal sinus rhythm
through heterogeneously connected myocytes traversing
dense unexcitable scar6 (Fig. 1). Post-infarct structuralFig. 1 eHistologic characterization of ischemic heart disease
substrates. Masson trichrome stain of infarcted
myocardium with “islands” of preserved myocardium
surrounded by scar tissue (blue). A schematized
representation of a possible ventricular tachycardia circuit is
depicted with the while lines. Slowed “zig-zag” conduction
through the “isthmus” of the circuit is represented by the
broken white lines. Adapted from Tung R, Boyle NG,
Shivkumar K. Circulation. 2011; 123(20):2284e2288.remodeling may also involve deposition of adipose tissue in
the infarcted bed. A recent report showed that electrophysi-
ologic consequences of post-infarct myocardial fatty
replacement in ovine MI included decreased conduction
velocity, and reduced bipolar electrogram amplitude.7 The
presence of inducible VT in MI animals was associated with
greater adipose content and slower conduction velocity in the
border zones of infarcts.
These structural changes alter local “sourceesink”
mismatch (in favor of the “source”), given the diminution in
electrotonic forces that minimize membrane voltage de-
viations in one (or a few) myocytes exerted via gap junctions.
Reductions in source-sink mismatch facilitate the genesis of
premature ventricular depolarizations, which trigger VTs.
2.2. Functional cellular remodeling
Remodeling of other important elements within and beyond
the infarcted myocardial bed also occur, and add further
complexity to the post-MI substrate. These include remodel-
ing of myocyte ionic currents and gap junctions, direction of
activation propagation, and intra-myocardial nerve fibers.
Although human data are lacking, studies in animal models
have provided insight into how ventricular myocyte action
potential (AP) remodel in cardiomyocytes adjacent to a healed
MI. These include reduction in the duration, upstroke ampli-
tude, and velocity of border zone myocyte AP.8 Reductions
have also been reported in peak calcium currents in surviving
border zone cells. In addition, refractoriness in the infarcted
animal heart is known to be more nonuniform compared to
normal hearts, with varying degrees of AP prolongation
exhibited by individual surviving myocytes adjacent to and
remote from the infarctedmyocardium. In the border zones of
infarcts, this worsens heterogeneity in refractorinesss, and
facilitates the development of unidirectional block, critical to
genesis and perpetuation of VT.
The distribution of connexin 43 gap junctions in the border
zone of the infarcted human heart is also aberrant. Fewer gap
junctions are organized into transverse (side-to-side) con-
nections, rather the gap junctions are redistributed in a lon-
gitudinal fashion.9 Detailed animal studies support light
microscopy findings in humans, with altered anisotropic
conduction in the healed infarct heart. In addition, interstitial
fibrosis results in displacement of myocytes from each other,
and a significant decrease in the syncytial connection of
myocytes in the infarct border zone.10
Another component of post-MI functional change is neural
remodeling. Nerve endings in the infarcted bed are resorbed,
however, since the neuronal cell body from which these
nerves originate is removed from the infarcted territory,
plastic growth is driven at the most distal intact endings
adjacent to the infarcted tissue. This nerve sprouting in the
border zone is heterogeneous, and is unable to penetrate scar
tissue. The presence of these sprouts has been associatedwith
ventricular arrhythmias and sudden death in humans,11 likely
related to local heterogeneity in myocyte electrophysiological
properties. We have demonstrated that the border zone of
infarcts exhibits variable responses to autonomic stress
(Fig. 2).12 Remodeling within stellate ganglia, which partly
control myocardial excitability, has also been reported, and
Fig. 2 e Heterogeneous responses to direct and reflex sympathetic nerve stimulation in scar, border zone, and preserved
myocardium. Image on the left depicts an electroanatomic map of a patient with a large anterior wall infarction (with dense
scar in gray, preserved myocardium in purple, and border zone in other colors) and the location of a multi-electrode
catheter. The image on the right shows the activation recovery interval (ARI) at baseline and in response to reflex
(nitroprusside) and direct (isoproterenol) sympathetic stimulation. In preserved myocardium, direct activation via
adrenergic receptors is fairly uniform, however in the border zone and scar regions, this response is heterogeneous,
reflecting varying degree of adrenergic receptor responses in adjacent myocardium. In response to reflex sympathetic
stimulation induced by cardiac sympathetic nerves, significant heterogeneity is seen across the entire spectrum of scar,
border zone, and even “preserved” myocardium. Adapted from Vaseghi M, Lux RL, Mahajan A et al. Am J Physiol Heart Circ
Physiol 2012, 302(9):H1838e46.
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heterogeneity seen after MI.13
In summary, the healed infarct heart exhibits changes in
the structural and functional characteristics of themyocardial
substrate. These alterations facilitate the conditions required
for initiation and maintenance of sustained reentrant ven-
tricular arrhythmias.3. Characterization of ischemic heart disease
substrates
3.1. Role of imaging
Myocardial imaging has an increasing role in the diagnosis and
treatment of VT in the ischemic heart disease substrate.
Contrast enhanced-magnetic resonance imaging (MRI) appears
to provide the most valuable information on cardiac structure,
owing to its superior resolution (Fig. 3A) over positron emission
tomography (PET) and computed tomography (CT).14
Pre-procedurally, imaging is used to identify the location
and transmurality of scar. Patchy scars (which may support
VT) and border zones of scar (where VT exit sites are typically
located) can be identified prior to the procedure to guide
mapping. Scar transmurality has been correlated to sites of
VT termination, as are sites with late potentials.15,16 A recent
study using CT showed consistent findings with MRI data,
with regards to post infarct wall thinning.17 Regions of het-
erogeneity in contrast enhanced MRI, also known as “gray
zones”, have been related to MMVT inducibility.
The resolution of in vivo MRI still has limitations, due to
partial volume effects from cardiac motion, making de-
terminations of transmurality suboptimal. The presence of
ICDs in most patients undergoing VT ablation raises concernsabout performing MRIs. At our center we have routinely per-
formed MR imaging in this patient population (except when
abandoned leads are present, or when the patient is pacing-
dependent) without adverse outcomes. Image artifacts
created by the device can also be minimized (Fig. 3B) to
improve the quality and usefulness of images obtained in
patients with devices.18 Intra-procedural imaging in contem-
porary VT ablation can be achieved with ICE,19 although its
utility extends beyond ablation of the ischemic substrate.
Intra-procedural MRI remains under development, however
its role in real-time characterization of lesion formation, and
ischemic substrate homogenization remains promising.20
3.2. Electrophysiologic characterization
3.2.1. Development and validation of electrogram amplitude
The characteristics of bipolar electrograms recorded from
normal myocardium and scar are distinct. This difference is
the basis of voltage mapping. Electrical signals are recorded
from cardiac tissue using catheters fitted with bipolar (or
multipolar) electrodes. These signals are filtered at 30e40Hz to
400e500 Hz, and bipolar electrograms demonstrating sharp bi
or tri-phasic waveforms with amplitudes greater than 3 mV
and durations under 70 ms are consistent with normal
myocardium. Bipolar electrograms with amplitudes less than
0.5 mV, showing durations >133 ms, and showing fraction-
ations are consistent with recordings from regions of
myocardial scar.21 Current mapping cut-offs utilize bipolar
electrogramamplitudes of>1.5mVand<0.5mV22 to delineate
normalmyocardium and dense scar respectively, with regions
demonstrating intermediate amplitudes designated as border-
zone areas (Fig. 4). These voltage thresholds have been vali-
dated in multiple studies. In a porcine healed infarct model,
Callans et al showed that bipolar electrograms <1 mV in
Fig. 3 e Characterization of ischemic heart disease substrates e magnetic resonance imaging. A An ex vivo magnetic
resonance image (MRI) of an infarcted porcine heart is shown (top image), with the corresponding Masson’s trichrome stain
of the same region shown in the inset. The high resolution of this MRI image relative to the histologic image can be readily
recognized. It should be noted that artifacts created by cardiac motion and presence of thoracic structures are not present in
ex vivo MR images. B The top left and right images depict an MR image before and after application of the WIDEBAND
method of device artifact attenuation. The bottom left and right images depict the corresponding voltage map (right anterior
oblique projection of left ventricular endocardium) showing consistency between the WIDEBAND (left) and electroanatomic
(right) location of scar. Adapted from Stevens SM, Tung R, Rashid S et al. Heart Rhythm 2013 in press.
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et al24 similarly correlated such areas in chronic infarcted
porcine heart with bipolar electrograms <1.5 mV and under
50 ms in duration. More detailed validation of electro-
anatomic data recorded in humans has been performed using
imaging modalities such as MRI, PET,25 and CT.17,26
3.2.2. Electroanatomic mapping
Electroanatomic mapping systems are capable of creating 3-D
myocardial geometry based on tissue contact, and superim-
pose color-coded characterization of normal, border zone, andFig. 4 e Bipolar electrogram morphology in ischemic heart
disease substrates. Representative examples of bipolar
electrograms (and amplitudes) recorded from regions of
“normal”, dense scar, and border zone myocardium are
shown superimposed onto a voltage map (0.5e1.5 mV). A
significant portion of the electrograms recorded in the
dense car region are “late” (i.e. occur well after the surface
QRS) and are very low in amplitude (<0.5 mV).dense scarmyocardial regions (Fig. 4). Myocardium is sampled
point-by-point, with the corresponding bipolar voltage
amplitude binned into scar (<0.5 mV), border zone
(0.5e1.5 mV), or normal (>1.5 mV) tissue. Intra-procedural
electrical characterization of the myocardial substrate using
one of the two available platforms (magnetic-based CARTO,
Biosense Webster, Diamond Bar, CA and electrofield-based
Ensite NaVX, St Jude Medical, Minneapolis, MN) is the stan-
dard in contemporary VT ablation.
The correlation between EAM data and CE-MRI delineation
of myocardial substrates remains imperfect. In a study by
Wijnmaalen et al, although there was excellent correlation
between infarcted regions on CE-MRI and electrical infarct
localization (bipolar electrogram <1.5 mV), scar areas on MRI
were significantly larger than scar areas delineated by EAM.27
In this study, approximately 20% of points taken in MRI-
designated regions of dense transmural scar recorded
“normal” bipolar electrograms (>1.5 mV). The converse may
also account for poor correlation between EAM and other
imagingmodalities or histopathology i.e. bipolar electrograms
<1.5 mV recorded from areas with normal tissue. The latter
issuemay arise due to poor catheter tissue contact or stability,
changes in the volume loaded state of the patient (increased
during EAM relative to imaging), inadequate delineation on
CE-MRI.4. Treatment of ventricular tachycardia in
ischemic substrates
4.1. Pharmacologic therapy
Despite decades of intense research and development, few
effective drugs with minimal side effects are available for the
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blockers have been studied in a variety of post-myocardial
infarction trials, demonstrating substantial reduction in the
risk of sudden death and recurrent VT28,29. The efficacy of beta
blockers in stable MMVT is however limited. Sotalol demon-
strates greater efficacy compared to beta blockers, however,
the risk of prolonged QT and PMVT restricts its use. The
proarrhythmic risk of anti-arrhythmics drugs in the post-
infarct setting have long been recognized,30,31 with amiodar-
one demonstrating a safer risk profile.32e34,23 Given the long-
term risk of side effects, amiodarone is a less favorable
choice for long-term management of VTs in ICM patients.
Newer agents such as ranolazine have shown some promise
in reducing VT and ICD shocks in ICM patients without
significantly increased risk profile.354.2. Defibrillator therapy
Implantable cardioverter-defibrillators have been demon-
strated in multiple trials to reduce the risk of sudden death in
patients with ischemic heart disease substrates.36 Although
defibrillators save lives, they do not prevent the initiation of
VT, and patients frequently present to medical attention with
repetitive ICD shocks. Defibrillator shocks are associated with
significant medical and psychiatric morbidity. Post hoc anal-
ysis of ICD studies demonstrate that patients who receive
appropriate ICD shocks have clinical outcomes that are less
favorable than those patients without VT and who do not
receive ICD shocks.37 While the underlying reason for this
phenomenon is not clear, it emphasizes that although de-
fibrillators have a role in preventing sudden death from ven-
tricular arrhythmias, adjunctive therapies are required to
mitigate arrhythmogenesis.Fig. 5 e Approach to catheter mapping and ablation of ventricu
cardioverter-defibrillator; NIPS: noninvasive programmed stimu
Mathuria N, Michowitz Y et al. Circ Arrhythmia Electrophysiol 204.3. Surgical treatment
In contemporary management of recurrent MMVT, surgical
therapy has a limited role. Although intraoperative mapping
studies provided substantial insights into the mechanisms
underlying scar-related VT,38,39 it has fallen out of favor due to
the morbidity of surgical exposure of the heart for mapping
and ablation.40 This is especially true in the era of minimally
based access to the endocardium and epicardium, and mini-
thoracotomy for epicardial access, which is increasingly
implemented.41,42 However, it is important to note that the
advent of border zone ablation was an attempt to mimic
encircling ventriculotomy and subendocardial resection.43,444.4. Catheter ablation
Catheter-based management of MMVT is an increasingly
adopted strategy, with a number of studies supporting its role
over antiarrhythmic drugs.45e48 It requires careful patient
selection, pre-procedural planning and imaging, procedural
substrate characterization, inductionandmappingof tolerable
MMVTs, ablation of electrophysiologic and substrate targets,
and careful post-procedural care, while minimizing risks of
complications. Catheter ablation is often reserved for patients
with ischemicheartdiseasewhosuffer ICDshocksor recurrent
arrhythmias (including electrical storm), although a growing
trend is the early introduction of catheter ablation of VT.
4.4.1. Identification of clinical VT
Patients may be inducible for multiple VT morphologies,
however, only one, or a few, may be responsible for the pa-
tient’s presentation. Identification of clinically relevant VT by
12-lead electrocardiogram, if possible, is important, as itlar tachycardia (VT). EGM: electrogram. ICD: implantable
lation; TCL: tachycardia cycle length. Adapted from Tung R,
12;5:264e272.
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The ventricular site of origin of the clinical VT deduced from a
12-lead ECG may also guide procedural planning and
approach. If the 12-lead ECG suggests an epicardial exit, pre-
paratory measures for epicardial access can be performed
before the procedure.49,50
For some patients, only ICD recordings of the clinical VT
may be available. The VT cycle length may be a useful clue to
the clinically relevant VT. Patients with devices can also un-
dergo a noninvasive programmed stimulation (NIPS) in the
day(s) prior to VT ablation, or at the start of the procedure. The
morphologies of inducible VTs can be noted on the electro-
physiologic recording systems, and used as templates during
the procedure, when the patient is typically under deeper
sedation. The morphologies of induced VTs can also be
compared to ICD recordings in terms of morphology and CL
for VTs that were monitored, or for which therapies were
delivered.51
4.4.2. Procedural strategy
Themajor determinant of mapping strategy is whether the VT
is hemodynamically tolerated. An approach, used at our
center, is detailed in the chart shown in Fig. 5.52 For hemo-
dynamically tolerated VTs, activation mapping is preferable,
as the origin of the VT can be mapped in detail for exit sites
and critical isthmuses showing diastolic potentials (Fig. 6).Fig. 6 e Entrainment and ablation of monomorphic
ventricular tachycardia (MMVT). Top panel: an MMVT with
a cycle length of 590 ms is entrained at 560 ms. The post-
pacing interval (PPI) is 590 ms, and exactly matches the
TCL. The stimulus to QRS (Stim-QRS) interval shown on the
last paced complex is 190 ms, which also exactly matches
the electrogram to QRS (EGM-QRS) interval at 190 ms. The
entrainment demonstrated here is also concealed (paced
QRS morphology is identical to MMVT QRS morphology,
i.e. no evidence of QRS fusion) These conditions
(PPI [ TCL, Stim-QRS [ EGM-QRS, and concealed
entrainment) confirm that the site is a protected and
critical isthmus for this MMVT. Lower panel: Ablation at
the site with entrainment characteristics demonstrated
above terminates MMVT immediately. Adapted from Tung
R, Boyle NG, Shivkumar K. Circulation.
2011;123(20):2284e2288.Entrainment mapping during VT can be performed to confirm
critical isthmuses or exit sites, and ablation performed.
Attention can then be focused on addressing the substrate
facilitating the clinical VT.
As most VTs are poorly tolerated hemodynamically, a
substrate mapping approach is more commonly used to guide
ablation. Strategies include anatomic and electrogram-based
approaches.
4.4.3. Substrate mapping e anatomic strategies
4.4.3.1. Border zone ablation & scar homogenization. Border
zone tissue has been shown to harbor both isthmus and exit
sites for MMVT.53,54 The strategy of border zone ablation relies
upon adequate mapping and electrophysiologic characteriza-
tion of the substrate, which can be facilitated by multipolar
catheters. Strategies to achieve border zone homogenization
includecreating linear lesions,45 transecting the scarwitha “T”
shaped lesion set, in addition to encircling.46 Substrate homog-
enization involves eradicating regions of preserved voltage
within dense scar regions, which may serve as isthmuses or
exit sites, and can be guided by abnormal electrograms.55
4.4.3.2. Identification and ablation of channels. As described
previously, channels bordered by electrically unexcitable scar
tissue form the basis for the majority of MMVTs. Adjusting
voltage settings during mapping may identify macroscopic
channels. Arenal et al demonstrated 23 channels in 20 pa-
tients using a tiered voltage threshold of 0.1e0.5 mV. Twenty
of such channels were related to a VTmorphology. In another
study utilizing a tiered scar display, a mean voltage threshold
of 0.33  0.15 mV was found to be optimal for identifying
channels, with an average observed channel length of
32  21 mm (range 12e87 mm).54
Channels have been alternatively identified by electro-
anatomicmapping during hemodynamically toleratedMMVT.
Channel characteristics identified include a mean length and
width of 31  7 mm and 16  8 mm respectively. In addition,
the location of the circuit was associated with channel
orientation, with perimitral circuits demonstrating channels
parallel to the mitral annulus, while all other channels were
oriented perpendicular in 21 studied patients. Confirming the
concept, ablation lesions transecting the narrowest portion of
a common channel terminated VT in 97% of cases. In contrast
to these studies, others have failed to find strong associations
between channels and critical isthmuses of VTs. Mountanto-
nakis and colleagues demonstrated that 88% of scar maps
contained channels using tiered voltage settings, however,
only 30% were shown by entrainment to contain the
isthmus.56
As noted earlier, these channels exist as a labyrinth in 3-D,
and may be interconnected. Our group assessed the connec-
tivity between channels, such that ablation of a critical LP
reflecting the common isthmus of these channels, causes
eradication of multiple channels (Fig. 7A).57
4.4.3.3. Multiple exit sites. Akin to multiple interconnected
channels, complex scars may also contain protected isth-
muses that are provided spatially distinct exits. This phe-
nomenon results in 2 distinct QRS morphologies from a
single stable pacing site, indicating multiple exits sites (MES)
Fig. 7 e Multiple exit sites and channels. A Schematic representation of interconnected channels with a common isthmus,
and three spatially separate exits, each producing a distinct QRS morphology. B The image on the left depicts the
electroanatomic map from a patient with inferior wall low voltage areas (0.5e1.5 mV). The electrogram recorded at an
isthmus site (inset, indicated by blue circle and arrow) with two exits is shown. Pacing at this site produced two distinct QRS
morphologies and two stimulus to QRS intervals (black and red box in top right tracing). One of the paced QRSmorphologies
(black box) matches the clinical VT (shown in right lower tracing). Adapted from Tung R, Mathuria N, Michowitz Y et al. Circ
Arrhythmia Electrophysiol 2012;5:264e272.
Fig. 8 e Distribution of late potentials in ischemic heart
disease substrates. An electroanatomic map is shown in
antero-posterior view depicting an anterior myocardial
infarction, with heterogeneous islets (HIs, regions of
preserved voltage within dense scar) shown. Very late
potentials (VLPs, green tags) were recorded around HIs or
dense scar (DS) areas. Mid-late potentials (MLPs, blue tags)
were recorded at scar border SB between DS and normal
tissue. Yellow dots reflect electrogram sampling points.
Adapted from Nakahara S, Tung R, Ramirez RJ et al. Heart
Rhythm 2010;7:1817e1824.
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recent report,52 our group defined an MES site as an abnormal
EGM site that produces 2 distinct QRS complexes with at
least three leads showing distinct QRS complexes qualita-
tively (Fig. 7B). When MES sites are identified and ablated, a
greater freedom from recurrent VT was seen, suggesting that
these are surrogates for critical isthmuses.52
4.4.4. Functional strategies
4.4.4.1. Late and abnormal potentials. Bipolar recording over
dense scar typically demonstrates late or absent activation,
owing to slower or absent conduction in this tissue. Local low
amplitude fractionated bipolar electrograms that have a
distinct onset after the end of the QRS complex are classified
as isolated late potentials (Fig. 8) in sinus or paced rhythm or
diastolic potentials in VT. These signals identify sites that are
activated later than the bulk of the ventricular tissue and have
been shown to have specificity as sites critical for reentry.
Ablation strategies specifically targeted at LPs have been
demonstrated to be effective in eradicating and preventing
recurrent VT.58,59
In the ischemic substrate, sites with LPs are encountered
more frequently than in the non-ischemic substrate.
Nakahara et al,60 showed that “very” late potentials (occurring
greater than 100ms after the surface QRS complex) were three
and two-fold more common in the endocardium and epicar-
dium respectively, of ischemic cardiomyopathy patients
relative to non-ischemic patients. Interestingly, when high-
density electroanatomic mapping was performed in patients
with ICM, heterogeneous islets (HI) (Fig. 8) with relatively
preserved voltage amplitudes were observed deep within
dense infarct scar.61 Fifty seven percent of sites demon-
strating vLPs were encountered within or adjacent to an HI.
This electrophysiologic finding is consistent with histologic
characterization of the healed infarct heart, as islands of
surviving myocardium are frequently encountered.
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mapping at a site of abnormal electrograms has been termed
pace map induction (PMI) (Fig. 9). The significance of this
finding is the identification of a functionally important site for
MMVT. The requisite for VT induction from this site is unidi-
rectional block, supporting unique characteristics of a critical
isthmus. Other features that may be observed during PMI are
concealed entrainment and longer stimulus to QRS interval,
further indications of MMVT isthmus sites. In our report,
ablation at a PMI site successfully terminated VT in 93% of
cases.52 Multiple distinct QRS morphologies may also be
observed during PMI, and PMImay identifymore relevant VTs.
Entrainment maneuvers can be performed after PMI to
confirm that a critical isthmushas been identified.5,62 Ablation
can be initiated rapidly, with the goal of terminating the VT
during energy delivery (Fig. 9, lower panel).
An often sought or important endpoint during ablation is
termination of VT early during RF delivery. Whether or not
this has any relationship to VT inducibility after RF delivery is
unclear. As most clinical MMVTs are poorly tolerated, me-
chanical hemodynamic support to permit mapping and
ablation during VT has been advocated by some. These
include intra-aortic balloon pump (IABP), TandemHeart &
Impella ventricular assist devices, and extra-corporeal mem-
brane oxygenation (ECMO). Whether clinical outcomes are
significantly improved in patients with poorly tolerated VT
who undergo substrate-based ablation compared to ventric-
ular assist devices is unclear.
4.4.5. Epicardial mapping and ablation
In patients with ischemic heart disease substrates, an
epicardial approach is often favored after previous failed
endocardial approach. This is in contrast to other substrates
such as Chagasic cardiomyopathy, arrhythmogenic right
ventricular cardiomyopathy (ARVC), or idiopathic dilated
cardiomyopathies where epicardial VT substrates are
encountered more frequently. The pericardial space is typi-
cally accessed via subxiphoid puncture using a Tuohy needle
as shown in Fig. 10, with an anterior or posterior entrance intoFig. 9 e Pace map induction (PMI). A representative tracing
showing PMI. Low amplitude electrograms with split
potentials (solid red circle on ablation catheter, Abl)
recorded at a site from which pacing induced a
monomorphic ventricular tachycardia (MMVT). The red
box indicates the first beat of MMVT. The split potentials
become diastolic potentials during MMVT (broken red
circle).the pericardial space selected based on whether the posterior
or anterior myocardium respectively, is the most likely origin
of VT. In most cases, use of angled sheaths and deflectable
catheters enables access to all aspects of the epicardium. In
patients who have had prior cardiac surgery, prior epicardial
access, or prior pericarditis, focal or global adhesions may be
present, restricting access to the pericardial space. Limited
surgical exposure can be utilized to gain epicardial access in
these cases.
The true incidence of epicardial VTs in ICM remains un-
known. As circuits may be transmural, termination of VT on a
given surface is an imperfect gold standard. Additionally, 12-
lead ECG localization only assists in determining the exit site,
which can be spatially remote from the critical isthmus.
Martinek et al demonstrated that traditional 12 lead criteria
lacked specificity in ICM substrates.63
Additionally, selection and referral bias are present in re-
ports from experienced tertiary centers. In patients referred
after failed endocardial ablation, epicardial substrate was
found in 71%. In our experience, where 81% of ICM patients
had failed a prior ablation, the long-term freedom from VT
was improved with combined endocardial-epicardial ablation
strategy.64 Di Biase et al55 demonstrated that a combined
endo-epicardial approach was better in ICM patients with
electrical storm, although a homogenization strategy was also
employed in this study, making it unclear whether critical
sites were on the endocardium or epicardium. The role of
combined endocardialeepicardial ablation as an initial strat-
egy requires further prospective investigation.
Risks of epicardial access include cardiac perforation and/
or tamponade, phrenic nerve palsy, hepatic laceration, bowel
perforation, pericarditis, and epicardial coronary arteryFig. 10 e Epicardial access and mapping for ventricular
tachycardia (VT). The left panel depicts an image of
epicardial access in the left anterior oblique (LAO)
projection. The Tuohy needed is seen entering the
pericardium as indicated, small amounts of contrast are
injected during the course of the needle to identify
structures passed in its trajectory. A J-tipped wire passed
through the needle into pericardial space outlines the
lateral heart border in LAO. The right panel image depicts
an epicardial voltage map in the LAO projection. A site
with late potentials during baseline paced rhythm is
shown (broken white circle and inset), as well as the
diastolic potentials recorded during VT.
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) s 2 4es 3 4S32injury. At our center, of 95 patients who underwent epicardial
access, complications were seen in 8.8% of cases (eight pa-
tients), including six (6.7%) cases of epicardial bleeding (one
confirmed RV puncture), and two patients with phrenic nerve
palsy. These complication rates are in line with multicenter
experience detailing the safety of epicardial mapping and
ablation of VT.655. Conclusion
After infarction, the myocardial substrate undergoes signifi-
cant structural and functional alterations, from amolecular to
macroscopic level, resulting in substrates capable of facili-
tatingMMVT. Themorbidity andmortality associated with VT
in this substrate cannot be overstated. Pharmacologic, and
catheter-based approaches to treating VT specific to this
substrate have evolved since the initial intraoperative map-
ping studies detailing critical elements of the ischemic sub-
strate. While the structural elements of the ischemic heart
disease substrate are well understood, the chronic functional
changes that permit unidirectional block and other key elec-
trophysiologic phenomena, as well as the acute functional
changes that initiate MMVT remain poorly understood.
Improving our understanding of this new frontier will un-
doubtedly improve or ability to prevent and care for patients
with ischemic heart disease substrates suffering from recur-
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